KYMR
Kymera Therapeutics Inc.
$89.68
+$1.87(+2.13%)
68
Overall
60
Value
83
Tech
63
Quality
Market Cap
$6.25B
Volume
1.86M
52W Range
$19.45 - $103.00
Target Price
$77.59
EPS Estimates Overview
| Current Quarter | $-0.79 | Next Quarter | $-0.94 |
| Current Year | $-3.48 | Next Year | $-3.74 |
| QoQ Growth | -19.0% | YoY Growth | -7.5% |
| 3Y EPS CAGR | -12.6% | Target Price | $77.59 |
| Consensus | Buy | Upside | -13.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $89.68 | +2.1% | 1.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW